CBD drugmaker GW Pharmaceuticals poised to raise $300 million
GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares.
News October 2GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares.
News October 2While Germany is on track to become one of the largest federally legal medical marijuana markets in the…
News September 24Months after the initial process was derailed by lawsuits, the German Federal Institute for Drugs and Medical Devices…
News September 20The United Kingdom likely will lean on imports to supply “unlicensed” cannabis-derived products after medical marijuana becomes available…
News September 13Monsanto pulled its Health Canada-approved pesticide from the cannabis market months ahead of a planned merger with German…
News September 12A French health agency has launched a temporary scientific committee to assess how to create a medical cannabis…
News September 11Germany intends to award the country’s first domestic licenses for medical cannabis cultivation in the first quarter of next…
News September 11The Netherlands has agreed to significantly increase shipments of medical cannabis to Germany to help the country cope…
News August 28While there are a lot of predictions about the direction of the EU cannabis market, one thing is…
News August 21Hours after Constellation Brands announced its marijuana-industry-record investment of 5 billion Canadian dollars ($3.8 billion) in Canada’s Canopy Growth, experts…
News August 16